Keywords
Skin test
Prevalence
Allergen-specific IgE
Hyaline rhinorrhea
Dust mites
Pollen
Abstract
Objective: Determine the prevalence of allergic rhinitis in school children.
Methods: Cross-sectional, descriptive study in children from 6 to 10 years old. Those who underwent skin testing (mites, pollens, fungi, cockroach, dog and cat hair) were included. The diagnosis of allergic rhinitis was made based on the test recommended by the European Academy of Allergy and Clinical Immunology (EAACI) and the American College of Allergy, Asthma and Immunology (ACAAI) for the diagnosis of allergy mediated by allergen-specific IgE. The statistical analysis included confidence interval for averages and percentages.
Results: In the 992 patients, the prevalence of allergic rhinitis was 15.7% (95% CI; 13.4-18.0), the predominant symptom was hyaline rhinorrhea in 94.7% (95% CI; 91.4-94.6), the main allergen was dust mites 60.4% (95% CI; 52.7-68.1) and pollen 59.3% (95% CI; 51.6-67.0).
Conclusion: The prevalence of allergic rhinitis in school children with positive skin tests is 15.7%, with a predominance of males with 63.1%.
Keywords: Allergic rhinitis; Skin test; Prevalence; Allergen-specific IgE; Hyaline rhinorrhea; Dust. Mites; Pollen.
References
1. Bousquet J, Anto JM, Bachert C, et al. Allergic rhinitis. Nat Rev Dis Primers 2020; 6 (1). doi: 10.1038/s41572-020-00227-0
2. Brozek JL, Bousquet J, Agache I, Agarwal A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol 2017; 140 (4): 950-958. doi: 10.1016/j.jaci.2017.03.050
3. Okubo K, Kurono Y, Ichimura K et al. Japanese guidelines for allergic rhinitis 2020. Allergol Int 2020; 69 (3): 331-345. doi: 10.1016/j.alit.2020.04.001
4. Urrutia-Pereira M, Fernandez C, Valentin-Rostan M, et al. Conocimiento de médicos de atención primaria sobre Rinitis Alérgica y su Impacto en el Asma (ARIA): estudio piloto comparativo Brasil, Paraguay, Uruguay. Rev Alerg Mex 2018; 65 (4): 321. doi: 10.29262/ram.v65i4.525
5. Vandenplas O, Vinnikov D, Blanc PD, et al. Impact of rhinitis on work productivity: a systematic review. J Allergy ClinI mmunol 2018; 6 (4): 1274-1286.e9. doi: 10.1016/j.jaip.2017.09.002
6. Castillo-Vizuete JA, Sastre J, del Cuvillo Bernal A, et al. Rinitis, poliposis nasal y su relación con el asma. Arch Bronconeumol 2019; 55 (3): 146-155. doi: 10.1016/j.arbres.2018.09.001
7. López García AI, Sacre Hazouri JA, Stone Aguilar H. Rinitis alérgica. En: Alergia, Asma e Inmunología Clínica en Pediatria. 2a ed. Nieto Editores; 2019: 95.
8. Hellings PW, Fokkens WJ, Akdis C, et al. Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today? Allergy 2012; 68 (1): 1-7. doi: 10.1111/all.12040
9. Muñoz Lopez F. Rinoconjuntivitis alérgica. Pediatr Integral 2013; 17 (8): 564-573.
10. Gelardi M, Iannuzzi L, Quaranta N, Landi M, et al. NASAL cytology: practical aspects and clinical relevance. Clin Amp Exp Allergy 2016; 46 (6): 785-792. doi: 10.1111/cea.12730
11. Ramírez-Soto M, Bedolla-Barajas M, González-Mendoza T. Prevalencia de asma, rinitis alérgica y dermatitis atópica en niños escolares en el Bajío de México. Rev Alerg Mex 2018; 65 (4): 372. doi: 10.29262/ram.v65i4.527
12. Mancilla-Hernández E, González-Solórzano EV, Medina-Ávalos MA, Barnica-Alvarado RH. Prevalencia de rinitis alérgica y de sus síntomas en la población escolar de Cuernavaca, Morelos, México. Rev Alerg Mex 2017; 64 (3): 243. doi: 10.29262/ram.v64i3.221
13. Asher MI, Stewart AW, Wong G, Strachan DP, et al. Changesover time in the relationship between symptoms of asthma, rhinoconjunctivitis and eczema: A global perspective from the International Study of Asthma and Allergies in Childhood (ISAAC). Allergol Immunopathol 2012; 40 (5): 267-274. doi: 10.1016/j.aller.2011.11.004
14. Suárez-Gutiérrez M, Macías-Garza JE, López-Ortiz DJ, Fuentes B, et al. Sensibilización a aeroalérgenos en pacientes con rinitis alérgica en Aguascalientes, México. Rev Alerg Mex 2020; 66 (4): 388. doi: 10.29262/ram.v66i4.634
15. Vázquez D, Medina I, Logusso G, Arias S, et al. Cross-sectional survey about the prevalence of allergic rhinitis in Argentina: Study PARA. Rev Alerg Mex 2019; 66 (1): 55. doi: 10.29262/ram.v66i1.543
16. Mancilla-Hernández E, Medina-Ávalos MA, Barnica-Alvarado RH, Soto-Candia D, et al. Prevalencia de rinitis alérgica en poblaciones de varios estados de México. Rev Alerg Mex. 2015; 62 (3): 196-201. doi: 10.29262/ram.v62i3.107
17. Cisneros Péres V, Alvarado Esquivel C. Prevalence of allergic rhinitis in Durango, Mexico. Rev Alerg Mex 2004; 51 (2): 49-53.
18. González-Díaz SN, Del Río-Navarro BE, Pietropaolo-Cienfuegos DR, et al. Factors associated with allergic rhinitis in children and adolescents from northern Mexico: International Study of Asthma and Allergies in Childhood Phase IIIB. Allergy Asthma Proc 2010; 31 (4): 53-62. doi: 10.2500/aap.2010.31.3346
19. Del Rio-Navarro BE, Luna-Pech JA, Berger A. Factors associated with allergic rhinitis in children from northern Mexico City. J Investig Allergol Clin Immunol 2007; 17 (2): 77-84..
20. López-Pérez G, Morfín-Maciel BM, Huerta-López J, et al. Risk factors related to allergic diseases at Mexico City. Rev Alerg Mex 2010; 57 (1): 18-25.
21. Mancilla-Hernández E, González-Solórzano EV. Prevalencia de rinitis alérgica y los síntomas como indicadores de riesgo en escolares de la sierra norte de Puebla. Rev Alerg Mex 2018; 65 (2): 140. doi: 10.29262/ram.v65i2.330.
22. Rodríguez-Galván YE, Ramos-García BD, Ramos-López JD. Prevalencia de asma, rinitis alérgica y dermatitis atópica en niños escolares de la zona centro en el estado de San Luis Potosí. Alerg Asma Inmunol Pediatr 2021; 30 (2): 43-49. doi: 10.35366/101641
23. Vázquez D, Onetti CI, Parisi CA, et al. Tratamiento de la rinitis alérgica en pediatría en Argentina. Documento de actualización. Rev Alerg Mex 2020; 67: S1-S28. doi: 10.29262/ram.v67i0.649
24. Bousquet J, Heinzerling L, Bachert C, et al. Practical guide to skin pricktests in allergy to aeroallergens. Allergy 2011; 67 (1): 18-24. doi: 10.1111/j.1398-9995.2011.02728.x
25. Patel G, Saltoun C. Skin testing in allergy. Allergy Asthma Proc 2019; 40 (6): 366-368. doi: 10.2500/aap.2019.40.4248.
26. Larenas-Linnemann D, Michels A, Dinger H, et al. Allergen sensitization linked to climate and age, not to intermittent-persistent rhinitis in a cross-sectional cohort study in the (sub)tropics. Clin Transl Allergy 2014; 4 (1). doi: 10.1186/2045-7022-4-20
27. Larenas-Linnemann D, Luna-Pech JA, Rodríguez-Pérez N et al. GUIMIT 2019, Guía Mexicana de Inmunoterapia. Guía de diagnóstico de alergia mediada por IgE e inmunoterapia aplicando el método ADAPTE. Rev Alerg Mex 2019; 66: 1-105. doi: 10.29262/ram.v66i5.631
28. Zuberbier T, Lötvall J, Simoens S, Subramanian SV, et al. Economic burden of inadequate management of allergic diseases in the EuropeanUnion: a GA2LEN review. Allergy 2014; 69 (10): 1275-1279. doi: 10.1111/all.12470
29. Tomás-Pérez M, González-Cavero L, Dominguez-Ortega J. Estudio de seguridad en inmunoterapia: práctica clínica en consulta de alergia. Rev Alerg Mex 2018; 65 (4): 357. doi: 10.29262/ram.v65i4.367
30. Cardona-Villa R, Sánchez A, Larenas-Linnemann D, Járes E, et al. Extractos alergénicos para inmunoterapia en Latinoamérica. Rev Alerg Mex 2018; 65 (1): 25. doi: 10.29262/ram.v65i1.287
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2025 Revista Alergia México